Clinical Trial Update: A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the long-term safety of ABT-089 in patients with mild-to-moderate Alzheimer's disease who participated in the M06-876 trial has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ABT-089

Snippet

Sponsor: Abbott | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED